Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Tevard and Zogenix collaborate on novel tRNA-based gene therapies for genetic epilepsies

Dec. 4, 2020

Serotonin found to differentially promote patience

Dec. 4, 2020

Zhejiang Hisun Pharmaceutical, Shanghai Aryl Pharmtech describe AGTR2 antagonists

Dec. 4, 2020

Novel Nav1.7 channel inhibitor with potent analgesic activity in a mouse model of neuropathic pain

Dec. 4, 2020

reMYND initiates first-in-human trial of ReS19-T for Alzheimer's

Dec. 3, 2020

Genethon cleared to begin clinical trial in France with GNT-0004 for Duchenne muscular dystrophy

Dec. 3, 2020

NEPTUNE study of OV-101 for Angelman syndrome misses primary endpoint

Dec. 2, 2020

Hetlioz approved in U.S. for nighttime sleep disturbances in Smith-Magenis syndrome

Dec. 2, 2020

New USP19 inhibitors described by Integral Health Holdings, Valo Early Discovery

Dec. 2, 2020

PTC initiates phase III study of vatiquinone for Friedreich's ataxia

Dec. 1, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 21, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...